
Sign up to save your podcasts
Or
Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.
4.8
1212 ratings
Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.
38,689 Listeners
90,949 Listeners
288 Listeners
12,103 Listeners
2,321 Listeners
69,085 Listeners
165,721 Listeners
59,349 Listeners
317 Listeners
12,348 Listeners
28,494 Listeners
15,335 Listeners
8,874 Listeners
9,964 Listeners
7,654 Listeners